John C. Molina

453 total citations
21 papers, 174 citations indexed

About

John C. Molina is a scholar working on Oncology, Public Health, Environmental and Occupational Health and Hematology. According to data from OpenAlex, John C. Molina has authored 21 papers receiving a total of 174 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 9 papers in Public Health, Environmental and Occupational Health and 9 papers in Hematology. Recurrent topics in John C. Molina's work include Acute Lymphoblastic Leukemia research (9 papers), CAR-T cell therapy research (9 papers) and Acute Myeloid Leukemia Research (7 papers). John C. Molina is often cited by papers focused on Acute Lymphoblastic Leukemia research (9 papers), CAR-T cell therapy research (9 papers) and Acute Myeloid Leukemia Research (7 papers). John C. Molina collaborates with scholars based in United States, India and Malaysia. John C. Molina's co-authors include Nirali N. Shah, Bonnie Yates, Daniel W. Lee, Crystal L. Mackall, Haneen Shalabi, Terry J. Fry, Seth M. Steinberg, Maryalice Stetler‐Stevenson, Constance M. Yuan and Hao‐Wei Wang and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancers.

In The Last Decade

John C. Molina

16 papers receiving 172 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John C. Molina United States 7 145 34 33 29 28 21 174
Jinlong Xu China 6 139 1.0× 23 0.7× 19 0.6× 37 1.3× 15 0.5× 16 177
Yue Tan China 6 151 1.0× 25 0.7× 20 0.6× 39 1.3× 15 0.5× 10 171
Patricia Steinert United States 6 178 1.2× 37 1.1× 87 2.6× 48 1.7× 51 1.8× 19 250
Nisha Ghatwai United States 4 184 1.3× 45 1.3× 34 1.0× 48 1.7× 14 0.5× 4 262
Khalid Shoumariyeh Germany 5 105 0.7× 15 0.4× 40 1.2× 41 1.4× 6 0.2× 11 141
Águeda Molinos-Quintana Spain 7 56 0.4× 20 0.6× 18 0.5× 31 1.1× 9 0.3× 9 117
Bruce L. Levine United States 4 158 1.1× 16 0.5× 9 0.3× 75 2.6× 32 1.1× 6 171
Renju Raj United States 7 85 0.6× 32 0.9× 81 2.5× 18 0.6× 17 0.6× 12 150
Remus Vezan United States 9 161 1.1× 24 0.7× 29 0.9× 95 3.3× 21 0.8× 17 238
Laura Motley United States 7 276 1.9× 69 2.0× 26 0.8× 49 1.7× 53 1.9× 9 300

Countries citing papers authored by John C. Molina

Since Specialization
Citations

This map shows the geographic impact of John C. Molina's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John C. Molina with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John C. Molina more than expected).

Fields of papers citing papers by John C. Molina

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John C. Molina. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John C. Molina. The network helps show where John C. Molina may publish in the future.

Co-authorship network of co-authors of John C. Molina

This figure shows the co-authorship network connecting the top 25 collaborators of John C. Molina. A scholar is included among the top collaborators of John C. Molina based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John C. Molina. John C. Molina is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Patel, Meera, Emily C. Zabor, Hadil Zureigat, et al.. (2025). Impact of TP53 mutation on survival outcomes in acute lymphoblastic leukemia at a tertiary center. Leukemia & lymphoma. 66(8). 1509–1514.
2.
Jain, Akriti, Sophia Balderman, John C. Molina, et al.. (2025). Clonal hematopoiesis in patients with non-hematologic cancers: Prevalence and detectability in primary tumor tissue.. Journal of Clinical Oncology. 43(16_suppl).
3.
Jain, Akriti, Joy Nakitandwe, Genevieve M. Crane, et al.. (2024). Impact of Non-ABL1 Mutations on Outcomes in Patients with Chronic Myeloid Leukemia. Blood. 144(Supplement 1). 3153–3153. 1 indexed citations
4.
Molina, John C. & Hetty E. Carraway. (2024). Treatment of Relapsed Acute Lymphocytic Leukemia in Adult Patients. Current Treatment Options in Oncology. 25(8). 993–1010. 3 indexed citations
5.
Patel, Meera, Hadil Zureigat, Emily C. Zabor, et al.. (2024). Impact of TP53 Mutation on Survival Outcomes in Acute Lymphoblastic Leukemia at a Tertiary Center. Blood. 144(Supplement 1). 4221–4221.
6.
Molina, John C.. (2024). Hematopoietic cell transplantation in CR1 may help mitigate the adverse outcomes of Ph-like B-ALL in adult patients. Transplantation and Cellular Therapy. 30(12). 1118–1120.
7.
Carraway, Hetty E., Harry Lesmana, John C. Molina, et al.. (2024). JAK2 p.R564 germ line variants associated with hereditary thrombocythemia and hematologic neoplasms. Blood Advances. 9(7). 1534–1543. 1 indexed citations
8.
Patel, Meera, Hadil Zureigat, Sara F. Haddad, et al.. (2024). Impact of P190 and P210 BCR::ABL1 Chimeric Protein on Outcomes of Acute Lymphoblastic Leukemia at a Tertiary Center. Blood. 144(Supplement 1). 5909–5909. 1 indexed citations
10.
DuVall, Adam, Brandon Hayes‐Lattin, Pinki Prasad, et al.. (2023). Gaps in Adolescent and Young Adult Cancer Education in Oncology Fellowship Training. Journal of Adolescent and Young Adult Oncology. 13(1). 97–104. 6 indexed citations
11.
Molina, John C. & Seth J. Rotz. (2023). Acute lymphoblastic leukemia in young adults: which up-front treatment?. Hematology. 2023(1). 573–580.
12.
Visconte, Valeria, Hetty E. Carraway, Aaron T. Gerds, et al.. (2023). Significance of the Apoptotic Regulators BAX, BCL2, BCL- XL and MCL1 in Newly Diagnosed AML. Blood. 142(Supplement 1). 5995–5995. 1 indexed citations
13.
Kuzmanovic, Teodora, M. R. Slaughter, David Bosler, et al.. (2023). Identification and management of clonal hematopoiesis of indeterminate potential (CHIP) in cancer survivors: The Cleveland Clinic experience.. Journal of Clinical Oncology. 41(16_suppl). 7010–7010. 1 indexed citations
14.
Molina, John C., Ting Zhou, Constance M. Yuan, et al.. (2022). Efficacy of second CAR-T (CART2) infusion limited by poor CART expansion and antigen modulation. Journal for ImmunoTherapy of Cancer. 10(5). e004483–e004483. 31 indexed citations
15.
Molina, John C. & Nirali N. Shah. (2021). CAR T cells better than BiTEs. Blood Advances. 5(2). 602–606. 20 indexed citations
16.
Mikkilineni, Lekha, Bonnie Yates, Seth M. Steinberg, et al.. (2021). Infectious complications of CAR T-cell therapy across novel antigen targets in the first 30 days. Blood Advances. 5(23). 5312–5322. 47 indexed citations
17.
Molina, John C., Seth M. Steinberg, Bonnie Yates, et al.. (2021). Factors Impacting Overall and Event-Free Survival following Post-Chimeric Antigen Receptor T Cell Consolidative Hematopoietic Stem Cell Transplantation. Transplantation and Cellular Therapy. 28(1). 31.e1–31.e9. 12 indexed citations
18.
Yates, Bonnie, Alexander Ling, Constance M. Yuan, et al.. (2021). Characterization of extramedullary disease in B-ALL and response to CAR T-cell therapy. Blood Advances. 6(7). 2167–2182. 35 indexed citations
19.
Molina, John C., Laura M. Tuschong, Robert R. West, et al.. (2020). Venetoclax/decitabine for a pediatric patient with chronic myelomonocytic leukemia. Pediatric Blood & Cancer. 68(3). 7 indexed citations
20.
Molina, John C., et al.. (1977). [Statements before the Subcommittee on Elementary, Secondary, and Vocational Education, Committee on Education and Labor, U.S. House of Representatives.].. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026